Pegasta Injection (Pegfilgrastim 6mg)

Description

Pegasta 6 mg Injection is a man-made form of human granulocyte colony-stimulating factor (G-CSF) analog. It stimulates the growth of white blood cells and helps in decreasing the chances of infection in patients who are undergoing chemotherapy procedures for cancer. Patients with blood disorders are advised not to use this medicine.

Side effects

Major & minor side effects for Pegasta 6 mg Injection
Chills
Cough
Fever
Sore throat
Mouth ulcers
Headache
Bone pain
Muscle pain
Nausea or Vomiting
Diarrhea

Uses of Pegasta 6 mg Injection

What is it prescribed for?
Neutropenia caused by chemotherapy
This medicine is used to reduce the incidence of infections in patients receiving myelosuppressive anti-cancer drugs associated with a clinically significant incidence of febrile neutropenia (fever with low WBC Count).
Neutropenia caused by radiation
This medicine is used to increase the survival rate in patients who have received high doses of myelosuppressive radiation.

Related Products

List of related products
Pegasta 6 mg Prefilled Syringe

When not to use?

Allergy
This medicine is not recommended for use in patients with a known allergy to filgrastim, pegfilgrastim or any other inactive ingredients present along with it.

Warnings

Warnings for special population
Pregnancy
This medicine is not recommended for use in pregnant women unless necessary. The risks and benefits should be discussed with the doctor before receiving this medicine.
Breast-feeding
This medicine is not recommended for use in breastfeeding women unless necessary. The risks and benefits should be discussed with the doctor before receiving this medicine. Your doctor may advise you to discontinue the drug or to discontinue breastfeeding based on your clinical condition
General warnings
Splenic Rupture
This medicine should be used with caution due to the increased risk of splenic rupture. Patients having abdominal and/or shoulder tip pain while receiving this medicine should consult the doctor immediately. Your doctor may advise you the appropriate corrective measure based on your clinical condition.
Acute Respiratory Distress Syndrome (ARDS)
This medicine has been shown to cause Acute respiratory distress syndrome in rare cases. Discuss the risks and benefits with your doctor before receiving this medicine. Report any symptoms of fever or respiratory distress to the doctor on priority. Replacement with a suitable alternative might be required in some cases based on the clinical condition.
Sickle cell crisis
This medicine not recommended for use in patients with a known history of sickle cell disease due to the increased risk of serious and life-threatening reactions. Discuss the risks and benefits with your doctor before receiving this medicine. Replacement with a suitable alternative might be required in some cases based on the clinical condition.

Dosage

Missed Dose
Since this medicine is administered by a qualified healthcare professional in the clinical or hospital setting, the likelihood of a missed dose is very low. If you miss an appointment for a scheduled dose of this medicine, contact your doctor immediately for further instructions.
Overdose
Since this medicine is administered in the hospital or clinical setting by a qualified healthcare professional, the likelihood of an overdose is very low. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.

Interactions

General Instructions
It is advised to administer this medicine under the supervision of a doctor or a trained healthcare professional. Your dose regimen and frequency of administration is likely to vary based on the condition being treated. Consult your doctor immediately if you develop any signs and symptoms of an infection.